A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension

NCT04936035 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

394

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Placebo
DRUG: ALN-AGT01

Sponsor

Alnylam Pharmaceuticals